TotalMarketCap

VivoSim Labs

VIVSNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$2.408 M

$0.15 -4.60%

Close of 6 Nov 2026

As of 6 Nov 2026, VivoSim Labs (VIVS) has a market capitalization of $2.41M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$131.0K

#3559 by revenue

Earnings

-$13.8M

Loss-making

Shares outstanding

3,494,071

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #158Liminatus PharmaLIMN$3.53M
  2. #159Tessera Defense & Homeland SecurityHLSQ$3.22M
  3. #160VivoSim LabsVIVS$2.41M
  4. #161Calidi BiotherapeuticsCLDI$2.32M
  5. #162Silexion TherapeuticsSLXN$2.19M

What if VivoSim Labs were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,702,402

Per share 11,724,529× higher

Bitcoin $1.53T

$92,113.98

Per share 634,394× higher

Apple $5.02T

$302,401.61

Per share 2,082,656× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for VivoSim Labs are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.